Baxter International Inc. Files Definitive Proxy Materials
Ticker: BAX · Form: DEFA14A · Filed: Mar 27, 2024 · CIK: 10456
Sentiment: neutral
Topics: proxy-filing, annual-meeting, sec-filing
Related Tickers: BAX
TL;DR
BAX proxy materials filed, standard annual meeting stuff.
AI Summary
Baxter International Inc. filed a Definitive Additional Materials proxy statement on March 27, 2024. This filing relates to the company's annual meeting and is not a preliminary proxy statement. Baxter International Inc. is headquartered in Deerfield, IL, and operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This filing is a standard procedural step for public companies to provide shareholders with information and materials necessary for voting at their annual meetings.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating any unusual financial or operational events.
Key Players & Entities
- BAXTER INTERNATIONAL INC (company) — Registrant
- DEERFIELD, IL (location) — Company Headquarters
- 3841 (industry_code) — Standard Industrial Classification
FAQ
What type of filing is this?
This is a Definitive Additional Materials filing (DEFA14A) for Baxter International Inc.
When was this filing made?
The filing was made on March 27, 2024.
What is Baxter International Inc.'s primary business sector?
Baxter International Inc. is in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, with SIC code 3841.
Where is Baxter International Inc. located?
The company's business and mailing address is One Baxter Parkway, Deerfield, IL 60015.
Is this a preliminary proxy statement?
No, this is a Definitive Additional Materials filing, not a Preliminary Proxy Statement.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 13.4 · Accepted 2024-03-27 16:33:27
Filing Documents
- d546571ddefa14a.htm (DEFA14A) — 11KB
- g546571g0327101021429.jpg (GRAPHIC) — 2KB
- 0001193125-24-078856.txt ( ) — 16KB
From the Filing
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX: Preliminary Proxy Statement Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Under Rule 14a-12 Baxter International Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX): No fee required. Fee paid previously with preliminary materials: Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. SUPPLEMENT TO PROXY STATEMENT DATED MARCH 25, 2024 FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 7, 2024 This supplement to the Proxy Statement, dated March 27, 2024 (this Supplement), supplements the definitive proxy statement filed by Baxter International Inc. (the Company) with the U.S. Securities and Exchange Commission (the SEC) on March 25, 2024 (the Proxy Statement) and made available to the Companys stockholders in connection with the solicitation of proxies by the Companys Board of Directors for use at the 2024 Annual Meeting of Stockholders, scheduled to be held virtually on Tuesday, May 7, 2024 at 9:00 a.m. Central Time (the Annual Meeting). This Supplement is being filed with the SEC and made available to stockholders on or about March 27, 2024. This Supplement updates the disclosure in the Proxy Statement in the section titled General InformationQuestions and Answers about the Annual MeetingWhat are broker non-votes and what effect do they have? on the effect of broker non-votes on the proposals deemed to be non-routine by the New York Stock Exchange. The second and third paragraphs of that section are hereby revised in their entirety to read as follows: Broker non-votes will have no impact on Proposal 1 Election of Directors. Broker non-votes will have the same effect as a vote against Proposal 2 Advisory Vote to Approve Named Executive Officer Compensation for 2023, Proposal 4 Approval of Baxter International Inc. Amended and Restated 2021 Incentive Plan, Proposal 5 Approval of an Amendment to the Amended and Restated Certificate of Incorporation to Permit Officer Exculpation and Proposal 6 Executives to Retain Significant Stock. Except as described in this Supplement, none of the items or information presented in the Proxy Statement is affected by this Supplement. This Supplement does not provide all of the information that is important to your voting decisions at the Annual Meeting, and the Proxy Statement contains other important additional information. This Supplement should be read in conjunction with the Proxy Statement. If you have already returned your proxy or voting instruction card or provided voting instructions, you do not need to take any action unless you wish to change your vote. This Supplement does not change the proposals to be acted upon at the Annual Meeting, which are described in the Proxy Statement.